Skip to content

Huang Qi Elixir for proteinuria in patients with diabetic nephropathy: a randomized controlled pilot tria

Huang Qi Elixir for proteinuria in patients with diabetic nephropathy: a randomized controlled pilot trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002718
Enrollment
Unknown
Registered
2012-11-23
Start date
2012-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic nephropathy

Interventions

Group D:Huang Qi Elixir decoction
Goup G10:Huang Qi Elixir granule 10 gram tid
Group G20:Huang Qi Elixir granule 20 gram tid
irbesartan group:irbesartan 150 mg qd

Sponsors

Teaching Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Other inclusion criteria include: (1) An age of 18 to 75 years; (2) Patients have acceptable glycemic control (FPG =30g/L; (5) Patients who provide written informed consent.

Exclusion criteria

Exclusion criteria: Patients will be excluded if they have any of the following: (1) Diabetes mellitus concurrent with non-diabetic kidney disease, kidney transplant recipients; (2) Concurrent severe disorders of heart, brain, liver and the hematopoietic system; (3) Newly diagnosed or relapsed tumors; (4) Mental disorders; (5) Intolerance to oral medications or severe malabsorption; (6) Hepatic dysfunction or the value of transaminase was higher than one and a half times the upper limit; (7) Allergy to TCM/ARBs or allergic institution; (8) Uncontrollable urinary infection and the infections which influence the measurements for urinary protein (9) Pregnancy or lactation; (10) Participation in other clinical trials within the past thirty days; (11) Anticipated survival < 1 year.

Design outcomes

Primary

MeasureTime frame
albumin-to-creatinine ratio;

Secondary

MeasureTime frame
glomerular filtration rate;serum creatinine;serum creatinine;glycosylated hemoglobin;

Countries

China

Contacts

Public ContactSen Zhong
zhongsen6606@163.com+86 028 87783910

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 10, 2026